Skip to content
2000
Volume 32, Issue 38
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Aim

We aimed to explore diagnostic biomarkers of postmenopausal osteoporosis (PMOP).

Background

PMOP brings enormous physical and economic burden to elderly women.

Objectives

This study aims to screen new biomarkers for osteoporosis, providing insights for early diagnosis and therapeutic targets of osteoporosis.

Methods

Weighted gene co-expression network analysis (WGCNA) was applied to identify osteoporosis-related hub genes. Single-cell transcriptomic atlas of osteoporosis was depicted and the heterogeneity of monocytes was analyzed, based on which the biomarkers for osteoporosis were screened. Gene set enrichment analysis (GSEA) was conducted on the biomarkers. The diagnostic model (nomogram) was established and evaluated based on the expression levels of biomarkers. Additionally, the transcription factor (TF) regulatory network was constructed to predict the potential TF and targeted miRNA of biomarkers. The drugs with significant correlation with biomarkers were identified by Spearman correlation analysis.

Results

We obtained 30 osteoporosis-associated hub genes. 9 cell types were identified, and the monocytes were subdivided to 4 subtypes. Three biomarkers, , , and , were screened. and were highly expressed in non-classical monocytes, while exhibited the highest expression in other monocytes, followed by non-classical monocytes. GSEA indicated that osteoporosis may be correlated with vascular calcification and the biomarkers may be involved in the formation of immune cells. Then, nomogram was constructed and exhibited good robustness. In addition, MYC and SETDB1 were the shared IF in three biomarkers, which may play critical regulatory roles in the progression of osteoporosis. Moreover, 41, 49, and 68 drugs appeared significant correlations with , , and , respectively.

Conclusion

This study provided a basis for early diagnosis and targeted treatment of osteoporosis.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673343344240930054414
2024-10-03
2025-11-01
Loading full text...

Full text loading...

References

  1. ChenP. LiZ. HuY. Prevalence of osteoporosis in China: A meta-analysis and systematic review.BMC Public Health2016161103910.1186/s12889‑016‑3712‑727716144
    [Google Scholar]
  2. KlingJ.M. ClarkeB.L. SandhuN.P. Osteoporosis prevention, screening, and treatment: A review.J. Womens Health (Larchmt.)201423756357210.1089/jwh.2013.461124766381
    [Google Scholar]
  3. LaiB. JiangH. GaoY. ZhouX. Identification of ROCK1 as a novel biomarker for postmenopausal osteoporosis and pan-cancer analysis.Aging (Albany NY)202315178873890710.18632/aging.20500437683138
    [Google Scholar]
  4. LinkT.M. Osteoporosis imaging: State of the art and advanced imaging.Radiology2012263131710.1148/radiol.1211046222438439
    [Google Scholar]
  5. AnderstW.J. WestT. DonaldsonW.F.III LeeJ.Y. Cervical spine bone density in young healthy adults as a function of sex, vertebral level and anatomic location.Eur. Spine J.20172692281228910.1007/s00586‑017‑5119‑228478522
    [Google Scholar]
  6. TsaiJ.N. UihleinA.V. LeeH. KumbhaniR. Siwila-SackmanE. McKayE.A. Burnett-BowieS.A.M. NeerR.M. LederB.Z. Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: The DATA study randomised trial.Lancet20133829886505610.1016/S0140‑6736(13)60856‑923683600
    [Google Scholar]
  7. KennelK.A. DrakeM.T. Adverse effects of bisphosphonates: Implications for osteoporosis management.Mayo Clin. Proc.200984763263810.1016/S0025‑6196(11)60752‑019567717
    [Google Scholar]
  8. ZhangZ. ZhangT. ZhouL. GuanJ. Identification of diagnostic genes and effective drugs associated with osteoporosis treatment by Single-Cell RNA-Seq analysis and network pharmacology.Mediators Inflamm.2022202211010.1155/2022/683063536199280
    [Google Scholar]
  9. HuG. ChengZ. WuZ. WangH. Identification of potential key genes associated with osteosarcoma based on integrated bioinformatics analyses.J. Cell. Biochem.20191208135541356110.1002/jcb.2863030920023
    [Google Scholar]
  10. WangY. MashockM. TongZ. MuX. ChenH. ZhouX. ZhangH. ZhaoG. LiuB. LiX. Changing technologies of RNA sequencing and their applications in clinical oncology.Front. Oncol.20201044710.3389/fonc.2020.0044732328458
    [Google Scholar]
  11. PapatheodorouI. MorenoP. ManningJ. FuentesA.M.P. GeorgeN. FexovaS. FonsecaN.A. FüllgrabeA. GreenM. HuangN. HuertaL. IqbalH. JianuM. MohammedS. ZhaoL. JarnuczakA.F. JuppS. MarioniJ. MeyerK. PetryszakR. Prada MedinaC.A. Talavera-LópezC. TeichmannS. VizcainoJ.A. BrazmaA. Expression Atlas update: From tissues to single cells.Nucleic Acids Res.201948D1gkz94710.1093/nar/gkz94731665515
    [Google Scholar]
  12. HuangR. WangX. YinX. ZhouY. SunJ. YinZ. ZhuZ. Combining bulk RNA-sequencing and single-cell RNA-sequencing data to reveal the immune microenvironment and metabolic pattern of osteosarcoma.Front. Genet.20221397699010.3389/fgene.2022.97699036338972
    [Google Scholar]
  13. SeyfinejadB. JouybanA. Importance of method validation in the analysis of biomarker.Curr. Pharm. Anal.202218656756910.2174/1573412918666211213142638
    [Google Scholar]
  14. ZhangC. LuoG. LinJ. ZhaoZ. LuoM. LiH. Identification of significant modules and hub genes involved in hepatic encephalopathy using WGCNA.Eur. J. Med. Res.202227126410.1186/s40001‑022‑00898‑336424620
    [Google Scholar]
  15. ZulibiyaA. WenJ. YuH. ChenX. XuL. MaX. ZhangB. Single-cell RNA sequencing reveals potential for endothelial-to-mesenchymal transition in tetralogy of fallot.Congenit. Heart Dis.202318661162510.32604/chd.2023.047689
    [Google Scholar]
  16. MuY. ZhengD. PengQ. WangX. ZhangY. YinY. WangE. YeF. WangJ. Integration of single-cell and bulk RNA-sequencing to analyze the heterogeneity of hepatocellular carcinoma and establish a prognostic model.Cancer Rep.202471e193510.1002/cnr2.193537994394
    [Google Scholar]
  17. JiJ. WuS. BaoX. LiuS. YeY. LiuJ. GuoJ. LiuJ. WangX. XiaZ. WeiL. ZhangY. HaoD. HuangD. Mediating oxidative stress through the Palbociclib/miR-141-3p/STAT4 axis in osteoporosis: A bioinformatics and experimental validation study.Sci. Rep.20231311956010.1038/s41598‑023‑46813‑637949959
    [Google Scholar]
  18. WangX. WangH. YuS. WangX. Diagnosis model of paraquat poisoning based on machine learning.Curr. Pharm. Anal.202218217618110.2174/1573412917666210302150150
    [Google Scholar]
  19. ZhuH. LinQ. GaoX. HuangX. Identification of the hub genes associated with prostate cancer tumorigenesis.Front. Oncol.202313116877210.3389/fonc.2023.116877237251946
    [Google Scholar]
  20. LiY. TangH. HuangZ. QinH. CenQ. MengF. HuangL. LinL. PuJ. YangD. Bioinformatics analysis and identification of genes and pathways involved in patients with Wilms tumor.Transl. Cancer Res.20221182843285710.21037/tcr‑22‑184736093523
    [Google Scholar]
  21. QiaoW. LiJ. XiongY. ZhengJ. JinR. HuC. GALAD score as a prognostic model for recurrence of hepatocellular carcinoma after local ablation.J. Cancer Res. Clin. Oncol.2024150524110.1007/s00432‑024‑05760‑z38713414
    [Google Scholar]
  22. ChenY. HuangL. WeiZ. LiuX. ChenL. WangB. Development and validation of a nomogram model to predict the prognosis of intrahepatic cholangiocarcinoma.Res. Squ.2022
    [Google Scholar]
  23. SunY. WangL. DuL. YuH. TianY. JinH. LiS. YanS. XiaoX. Investigation on the mechanism of Ginkgo Folium in the treatment of non-alcoholic Fatty Liver Disease by strategy of network pharmacology and molecular docking.Technol. Health Care202331S120922110.3233/THC‑23601837038793
    [Google Scholar]
  24. MaeserD. GruenerR.F. HuangR.S. oncoPredict: An R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data.Brief. Bioinform.2021226bbab26010.1093/bib/bbab26034260682
    [Google Scholar]
  25. LvY. HuJ. ZhengW. ShanL. BaiB. ZhuH. DaiS. A WGCNA-based cancer-associated fibroblast risk signature in colorectal cancer for prognosis and immunotherapy response.Transl. Cancer Res.20231292256227510.21037/tcr‑23‑26137859738
    [Google Scholar]
  26. SuY.J. ChenC.T. TsaiN.W. HuangC.C. WangH.C. KungC.T. LinW.C. ChengB.C. SuC.M. HsiaoS.Y. LuC.H. The role of monocyte percentage in osteoporosis in male rheumatic diseases.Am. J. Men Health20171161772178010.1177/155798831772164228901203
    [Google Scholar]
  27. DhoteV. SweeneyT.R. KimN. HellenC.U.T. PestovaT.V. Roles of individual domains in the function of DHX29, an essential factor required for translation of structured mammalian mRNAs.Proc. Natl. Acad. Sci. USA201210946E3150E315910.1073/pnas.120801410923047696
    [Google Scholar]
  28. DaiL. TanQ. LiL. LouN. ZhengC. YangJ. HuangL. WangS. LuoR. FanG. XieT. YaoJ. ZhangZ. TangL. ShiY. HanX. High-throughput antigen microarray identifies longitudinal prognostic autoantibody for chemoimmunotherapy in advanced non-small cell lung cancer.Mol. Cell. Proteomics202423510074910.1016/j.mcpro.2024.10074938513890
    [Google Scholar]
  29. ZhuQ. TanP. LiY. LinM. LiC. MaoJ. CuiJ. ZhaoW. WangH.Y. WangR.F. DHX29 functions as an RNA co-sensor for MDA5-mediated EMCV-specific antiviral immunity.PLoS Pathog.2018142e100688610.1371/journal.ppat.100688629462185
    [Google Scholar]
  30. ZhouH. GulY. HameedY. AlhomraniM. AlghamdiS.A. AlmalkiA.A. AlsuwatM.A. ALSuhaymiN. NazR. ChenG. Unveiling the unexplored novel signatures for osteoporosis via a detailed bioinformatics and molecular experiments based approach.Am. J. Transl. Res.20241641306132110.62347/TAYD331838715824
    [Google Scholar]
  31. Perez-SantángeloS. ManciniE. FranceyL.J. SchlaenR.G. ChernomoretzA. HogeneschJ.B. YanovskyM.J. Role for LSM genes in the regulation of circadian rhythms.Proc. Natl. Acad. Sci. USA201411142151661517110.1073/pnas.140979111125288739
    [Google Scholar]
  32. HuangM. AtreyaM.R. HolderA. KamaleswaranR. A machine learning model derived from analysis of time- course gene-expression datasets reveals temporally stable gene markers predictive of sepsis mortality.Shock202360567167710.1097/SHK.000000000000222637752077
    [Google Scholar]
  33. KryczkaJ. BoncelaJ. Integrated bioinformatics analysis of the hub genes involved in irinotecan resistance in colorectal cancer.Biomedicines2022107172010.3390/biomedicines1007172035885025
    [Google Scholar]
  34. LiuQ. LianQ. SongY. YangS. JiaC. FangJ. Identification of LSM family members as potential chemoresistance predictive and therapeutic biomarkers for gastric cancer.Front. Oncol.202313111994510.3389/fonc.2023.111994537007092
    [Google Scholar]
  35. ZhuangH. ChenB. TangC. ChenX. TanW. YangL. XieZ. MaX. WangQ. ZhangC. ShangC. ChenY. Identification of LSM family members as novel unfavorable biomarkers in hepatocellular carcinoma.Front. Oncol.20221287177110.3389/fonc.2022.87177135646684
    [Google Scholar]
  36. ZhaoY. LongM.J.C. WangY. ZhangS. AyeY. Ube2V2 is a rosetta stone bridging redox and ubiquitin codes, coordinating DNA damage responses.ACS Cent. Sci.20184224625910.1021/acscentsci.7b0055629532025
    [Google Scholar]
  37. LiS. ChenB. ChenH. HuaZ. ShaoY. YinH. WangJ. Analysis of potential genetic biomarkers and molecular mechanism of smoking-related postmenopausal osteoporosis using weighted gene co-expression network analysis and machine learning.PLoS One2021169e025734310.1371/journal.pone.025734334555052
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673343344240930054414
Loading
/content/journals/cmc/10.2174/0109298673343344240930054414
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test